Half-year report · Q2
4583.TEDINET S100WIB0
Period2025-01-01 → 2025-06-30
Filed2025-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 42
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥252m | 2025-01-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥781m | 2024-01-01 → 2024-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥264m | 2024-01-01 → 2024-06-30 | Standalone | Net sales |
| Operating income | −¥537m | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | −¥581m | 2024-01-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | −¥539m | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥1.0bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥563m | 2024-01-01 → 2024-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥539m | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥562m | 2024-01-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | −¥540m | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | −¥1.0bn | 2024-01-01 → 2024-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥564m | 2024-01-01 → 2024-06-30 | Standalone | Profit loss |
| Total assets | ¥2.0bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥1.6bn | at 2024-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥443m | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥549m | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.5bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2024-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2023-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥673m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.0bn | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥677m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in operating activities |
| Financing cash flow | ¥85m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.7bn | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥455m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-7.97 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.54 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.21 | 2024-01-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.9% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.4% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.0% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 68,053,800 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 66,969,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 56,387,000 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥280m |
| jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥396m |
| jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥252m |
| jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥252m |
| jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥139m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥252m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥252m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | −¥257m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥269m |
| jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥447m |
| jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥264m |
| jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥264m |
| jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥135m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥264m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥264m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | −¥312m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 427
| Item | Context | Value | Unit |
|---|---|---|---|
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都渋谷区本町三丁目12番１号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Type1 semi annual financial statements financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Note on change of independent auditors financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は子会社がありませんので、中間連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding inventories (text) | CurrentQuarterInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding research and development expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes financial instruments quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes securities quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |